Clinical trials play a crucial role in the development of new therapeutics and vaccines, allowing drug manufacturers to evaluate the safety and efficacy of new medicines in a controlled manner. As the complexity of clinical trials increases — owing to globalization, technological innovation, evolving decentralized models, patient centric concerns, and the challenges posed by the COVID-19 pandemic — it is crucial that trials sponsors form strategic relationships to assure reliable supply of all needed clinical trials materials, including the sourcing of comparator drugs.
By assigning our dedicated team to your comparator needs, EarlyHealth Group simplifies the complexity of your study. Bearing in mind that more than half of clinical studies fail due to operational deficiencies, we provide a tailor-made comparator sourcing strategy for your studies to stay on track without wastage.
Securing reliable relationships with manufacturers and their territory agents is critical for continuity planning of your clinical study. For comparator sourcing, whether direct from manufacturer or from our robust network of distributors, we ensuring longest expiry, sequential batches and product documents (COA, Batch Certificate, Equivalence Statement, COO).
With GDP compliant facilities across Asia, Europe, Middle East and the Americas, we ensure strict quality and regulatory management for the safety of the product and study. All transactions are fully documented with supply chain pedigree, temperature monitoring and delivery records till clinical study site.
We understand that every project is unique. With a dedicated project manager, we leverage on years of expertise to ensure a successful delivery of services, from regulatory to delivery to site. From study sites in US, EU, China and Russia, our team will guide you along the way and ensure material arrives at the multiple sites.
Whether you are a Sponsor, CRO or CTS company, let EarlyHealth prepare you a proposal for your next clinical trial sourcing requirements, and see how our long terms relationships with manufacturers can be leveraged on for a discrete, reliable and cost-effective sourcing.
Copyright © 1993-2021 EarlyHealth Group
This website uses cookies. By continuing to use this site, you accept our use of cookies.